EICHOR
● Completed
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
Condition: Arthritis, Psoriatic · Sponsor: Janssen Research & Development, LLC
About this study
The primary purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (138)
| Rheumatology Associates | Birmingham, Alabama, United States | — |
| Arizona Arthritis & Rheumatology Associates PC | Glendale, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Mesa, Arizona, United States | — |
| Clinical Research Center of Connecticut | Danbury, Connecticut, United States | — |
| Dawes Fretzin Clinical Research Group LLC | Indianapolis, Indiana, United States | — |
| University of Michigan | Ann Arbor, Michigan, United States | — |
| Arthritis Consultants | St Louis, Missouri, United States | — |
| Austin Regional Clinic | Austin, Texas, United States | — |
| Multiprofile Hospital for Active Treatment Plovdiv | Plovdiv, Bulgaria | — |
| Multiprofile Hosptal for Active Treatment Eurohospital Plovdiv | Plovdiv, Bulgaria | — |
| Medical Center Teodora | Rousse, Bulgaria | — |
| Diagnostic Consulting Center No 17 | Sofia, Bulgaria | — |
+ 126 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03158285